Sangamo Biosciences (SGMO) Stock Statistics & Valuation Metrics

Sangamo Biosciences has a market cap or net worth of $157.00M. The enterprise value is $174.15M.

Sangamo Biosciences has 224.71M shares outstanding. The number of shares has decreased by -2.65% in one year.

Sangamo Biosciences’s return on equity (ROE) is -4.30 and return on invested capital (ROIC) is -172.58%.

The current PE Ratio of Sangamo Biosciences is -2.10. Sangamo Biosciences’s PEG ratio is 0.03.

In the last 12 months, Sangamo Biosciences had revenue of $57.80M and earned -$97.94M in profits. Earnings per share was -$0.53.

In the last 12 months, operating cash flow was -$67.14M and capital expenditures -$267.00K, giving a free cash flow of -$67.41M billion.

Sangamo Biosciences pays an annual dividend of , resulting in a dividend yield of

Sangamo Biosciences upcoming earnings date is Apr 30, 2025, After Close.

Sangamo Biosciences as a current ratio of 1.13, with Debt / Equity ratio of 1.34

In the past 12 months, Sangamo Biosciences has paid -$167.00K in taxes.

Sangamo Biosciences EV to EBITDA ratio is -2.18, with an EV/FCF ratio of -2.88.

Sangamo Biosciences has $41.92M in cash and marketable securities with $30.57M in debt, giving a net cash position of -$11.35M billion.

Gross margin is 100.00%, with operating margin of -179.88%, and net profit margin of -169.45%.

The average price target for Sangamo Biosciences is $5.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy